Delivery Order SPE2DB22D2218-SPE2DB25FR3AS
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Difluprednate 0.05% eye drops. The contract has a ceiling value of $2,287.42 and a period of performance through May 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Difluprednate 0.05% eye drops in 5 milliliter vials, with a ceiling value of $1,555.44 and a performance period through April 29, 2024. The contract is a firm fixed price delivery order, placed under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a $1,362.00 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DIFLUPREDNATE 0.05% EYE DROP 5ML, a specialty medication, to support military healthcare programs. The delivery order has a completion date of June 29, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The delivery order is for the supply of difluprednate 0.05% eye drops in 5 ml containers, with a ceiling value of $3,965.92 and a completion date of March 8, 2023. The contract was awarded on a full and open competition basis, without any set-aside designation....
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $3,807.19 firm fixed price delivery order is for the provision of Difluprednate 0.05% eye drops, 5 ml. The contract has a completion date of February 28, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,309.01 firm fixed-price contract is for the supply of DIFLUPREDNATE 0.05% EYE DROP 5ML, a pharmaceutical product. The contract has a completion date of June 7, 2024. No set-aside designation was used for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Difluprednate 0.05% eye drops. The $1,143.36 award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a wholly owned subsidiary of the Amerisourcebergen Corporation. The $5,003.35 contract is for the supply of Difluprednate 0.05% eye drops in 5 milliliter vials. The award is associated with a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp to provide a comprehensive range of pharmaceutical products and...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of DIFLUPREDNATE 0.05% eye drops. The $1,549.50 contract has a completion date of May 2, 2023 and does not have a set-aside designation, indicating full and open competition. AmerisourceBergen Drug Corporation is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract...
- This contract award, valued at $3,179.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Difluprednate 0.05% eye drops in 5ml quantities. This is a firm-fixed price delivery order contract with a completion date of February 14, 2023. The award is not associated with any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
- SPE2DB22D2218Indefinite Delivery Contract
- SPE2DB22D2218-SPE2DB25FR3ASDelivery Order
The Defense Logistics Agency awarded a $1,043.01 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Difluprednate 0.05% eye drops in 5ml quantities. This firm fixed-price contract, which carries an ultimate completion date of July 29, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, and performance will be executed from the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant $999.999 billion IDC with DLA Troop Support Medical (SPE2DX) extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. The current delivery order for Difluprednate eye drops exemplifies the company's role as a critical federal medical procurement vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 7/28/25 |